Renaissance Technologies
GLMD icon

Renaissance Technologies’s Galmed Pharmaceuticals GLMD Stock Holding History

Renaissance Technologies’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-35
Closed -$16K – 4216
2022
Q3 		$16K Buy
35
+13
+59% +$8.88K ﹤0.01% 3918
2022
Q2 		$21K Buy
+22
New +$29.2K ﹤0.01% 4111
2021
Q2 		– Sell
-42
Closed -$208K – 3574
2021
Q1 		$208K Sell
42
-38
-48% -$210K ﹤0.01% 3137
2020
Q4 		$360K Buy
80
+56
+233% +$280K ﹤0.01% 2970
2020
Q3 		$121K Sell
24
-30
-56% -$196K ﹤0.01% 3184
2020
Q2 		$373K Buy
54
+26
+93% +$175K ﹤0.01% 2969
2020
Q1 		$139K Sell
28
-17
-38% -$129K ﹤0.01% 3170
2019
Q4 		$375K Buy
45
+34
+309% +$234K ﹤0.01% 2998
2019
Q3 		$79K Sell
11
-11
-50% -$88.3K ﹤0.01% 3290
2019
Q2 		$237K Sell
22
-1
-4% -$10.3K ﹤0.01% 3261
2019
Q1 		$268K Hold
23
– – ﹤0.01% 3130
2018
Q4 		$229K Buy
+23
New +$321K ﹤0.01% 3101
2018
Q2 		– Sell
-62
Closed -$500K – 3369
2018
Q1 		$500K Buy
62
+36
+138% +$420K ﹤0.01% 2915
2017
Q4 		$345K Buy
+26
New +$307K ﹤0.01% 2982
2016
Q3 		– Sell
-8
Closed -$49K – 3386
2016
Q2 		$49K Buy
+8
New +$60.5K ﹤0.01% 3234
2015
Q3 		– Sell
-8
Closed -$109K – 3230
2015
Q2 		$109K Sell
8
-4
-33% -$55.7K ﹤0.01% 3078
2015
Q1 		$159K Buy
+12
New +$144K ﹤0.01% 2936

Other funds holding GLMD

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $3.06B AUM 26.31% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Renaissance Technologies's GLMD Position: Q4 2022 in Review

Renaissance Technologies sold out of Galmed Pharmaceuticals (GLMD) in Q4 2022, closing a stake of 35 shares — an estimated $16K sold.

Renaissance Technologies first reported a position in GLMD in Q1 2015 and held it in 17 quarters. The position peaked at $500K in Q1 2018. 19 funds tracked by Wall St. Rank hold GLMD as of Q4 2022.

  • Renaissance Technologies reported no remaining Galmed Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Renaissance Technologies sold 35 Galmed Pharmaceuticals shares in Q4 2022, an estimated $16K.
  • Renaissance Technologies first reported a position in Galmed Pharmaceuticals in Q1 2015 and held it in 17 quarters.
  • Renaissance Technologies's Galmed Pharmaceuticals position peaked at $500K in Q1 2018.
  • 19 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q4 2022.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.